VRCA insider filings

Verrica Pharmaceuticals Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen VRCA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VRCA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Verrica Pharmaceuticals Inc.

FiledFormInsiderReported transactionsSource
2026-08-184Kirby John J. — Interim CFOPurchase (P): 5,000 @ $4.93EDGAR
2026-08-184Rosenberg Noah L. — CMOPurchase (P): 4,200 @ $4.91 · Purchase (P): 2,030 @ $4.92EDGAR
2026-08-184Rieger Jayson — CEO and President, DirectorPurchase (P): 20,000 @ $5.06 · Purchase (P): 5,000 @ $4.91EDGAR
2026-08-184Zawitz David — Chief Operating OfficerPurchase (P): 6,000 @ $4.98EDGAR
2026-06-094Zawitz David — Chief Operating OfficerGrant/award (A): 171,340 (derivative) @ $0EDGAR
2026-06-094Rieger Jayson — CEO and President, DirectorGrant/award (A): 512,269 (derivative) @ $0EDGAR
2026-06-094Eichenfield Lawrence — DirectorGrant/award (A): 16,000 (derivative) @ $0EDGAR
2026-06-094Nguyen Diem — DirectorGrant/award (A): 16,000 (derivative) @ $0EDGAR
2026-06-094Corcoran Gavin — DirectorGrant/award (A): 16,000 (derivative) @ $0EDGAR
2026-06-094Rosenberg Noah L. — CMOGrant/award (A): 233,840 (derivative) @ $0EDGAR
2026-06-094PRYGOCKI MARK A SR — DirectorGrant/award (A): 16,000 (derivative) @ $0EDGAR
2025-12-304Kirby John J. — Interim CFOGrant/award (A): 10,000 @ $0EDGAR
2025-11-254Zawitz David — Chief Operating OfficerPurchase (P): 10,000 @ $4.24 · Purchase (P): 2,500 (derivative)EDGAR
2025-11-254Rieger Jayson — CEO and President, DirectorPurchase (P): 94,311 @ $4.24 · Purchase (P): 23,577 (derivative)EDGAR
2025-11-254Rosenberg Noah L. — CMOPurchase (P): 2,357 @ $4.24 · Purchase (P): 589 (derivative)EDGAR
2025-11-254Kirby John J. — Interim CFOPurchase (P): 3,536 @ $4.24 · Purchase (P): 884 (derivative)EDGAR
2025-11-254Manning Paul B — Director, 10% ownerPurchase (P): 1,375,380 @ $4.24 · Purchase (P): 2,750,762 @ $4.24 · Purchase (P): 343,845 (derivative) · Purchase (P): 687,690 (derivative)EDGAR
2025-06-094Corcoran Gavin — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-094Nguyen Diem — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-094Eichenfield Lawrence — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-094PRYGOCKI MARK A SR — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-04-024Corcoran Gavin — DirectorGrant/award (A): 17,502 (derivative) @ $0EDGAR
2025-03-264Rosenberg Noah L. — CMOGrant/award (A): 325,000 (derivative) @ $0EDGAR
2025-03-184Rieger Jayson — CEO and President, DirectorGrant/award (A): 850,000 (derivative) @ $0EDGAR
2025-03-184Hayes Christopher G. — CHIEF LEGAL OFFICERSale (S): 4,315 @ $0.65 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2025-02-064/AGoldenberg Gary — Chief Medical OfficerGrant/award (A): 50,000 @ $0EDGAR
2025-02-064/AKohler Terry — CHIEF FINANCIAL OFFICERGrant/award (A): 125,000 @ $0EDGAR
2025-02-064/AHayes Christopher G. — CHIEF LEGAL OFFICERGrant/award (A): 150,000 @ $0EDGAR
2025-02-064/AWhite Ted — PRESIDENT AND CEO, DirectorGrant/award (A): 150,000 @ $0EDGAR
2025-02-064/ABonaccorso Joe — CHIEF COMMERCIAL OFFICERGrant/award (A): 125,000 @ $0EDGAR
2024-12-094Zawitz David — Chief Operating OfficerGrant/award (A): 950,000 (derivative) @ $0EDGAR
2024-11-264Rieger Jayson — CEO and President, DirectorPurchase (P): 280,898 · Gift (G): 50,000 @ $0 · Purchase (P): 140,449 (derivative) · Purchase (P): 140,449 (derivative)EDGAR
2024-11-264Stalfort John A III — DirectorPurchase (P): 1,123,595 · Gift (G): 50,000 @ $0 · Purchase (P): 561,797 (derivative) · Purchase (P): 561,797 (derivative)EDGAR
2024-11-264Manning Paul B — Director, 10% ownerPurchase (P): 18,426,966 · Purchase (P): 4,494,382 · Gift (G): 450,000 @ $0 · Purchase (P): 9,213,483 (derivative) · Purchase (P): 9,213,483 (derivative) · Purchase (P): 2,247,191 (derivative) · +1 moreEDGAR
2024-11-064Rieger Jayson — CEO and President, DirectorGrant/award (A): 2,000,000 (derivative) @ $0EDGAR
2024-11-064Kirby John J. — Interim CFOGrant/award (A): 54,267 @ $0EDGAR
2024-10-114Hayes Christopher G. — CHIEF LEGAL OFFICERGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-09-234Manning Paul B — Director, 10% ownerGift (G): 2,675,611.25 @ $0 · Gift (G): 891,870.41 @ $0 · Gift (G): 891,870.42 @ $0 · Gift (G): 891,870.42 @ $0EDGAR
2024-08-284Hayes Christopher G. — CHIEF LEGAL OFFICERSale (S): 26,183 @ $2.66 · Sale (S): 9,530 @ $2.46EDGAR
2024-08-284Goldenberg Gary — Chief Medical OfficerSale (S): 9,888 @ $2.66 · Sale (S): 3,601 @ $2.46EDGAR
2024-08-284Bonaccorso Joe — CHIEF COMMERCIAL OFFICERSale (S): 24,709 @ $2.66 · Sale (S): 8,993 @ $2.46EDGAR
2024-08-284Kohler Terry — CHIEF FINANCIAL OFFICERSale (S): 21,820 @ $2.66 · Sale (S): 7,899 @ $2.46EDGAR
2024-08-284White Ted — PRESIDENT AND CEO, DirectorSale (S): 24,979 @ $2.66 · Sale (S): 9,021 @ $2.46EDGAR
2024-07-234Bonaccorso Joe — CHIEF COMMERCIAL OFFICERSale (S): 25,461 @ $7.06 · Sale (S): 115 @ $6.98EDGAR
2024-07-234White Ted — PRESIDENT AND CEO, DirectorSale (S): 32,469 @ $7.06 · Sale (S): 154 @ $6.98EDGAR
2024-07-234Goldenberg Gary — Chief Medical OfficerSale (S): 18,421 @ $7.06 · Sale (S): 86 @ $6.98EDGAR
2024-07-234Hayes Christopher G. — CHIEF LEGAL OFFICERSale (S): 21,649 @ $7.06 · Sale (S): 91 @ $6.98EDGAR
2024-06-074Eichenfield Lawrence — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2024-06-074Ballaron Craig — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2024-06-074PRYGOCKI MARK A SR — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Verrica Pharmaceuticals Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-248-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VRCA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs